By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > Investing > Apogee Therapeutics files for IPO
Investing

Apogee Therapeutics files for IPO

News Room
Last updated: 2023/06/23 at 8:09 AM
By News Room
Share
1 Min Read
SHARE

Apogee Therapeutics Inc. has filed for an initial public offering, according to a filing late Thursday. The biotech company did not provide the number of shares it intends to sell or a price range. Underwriters include ​Jefferies and TD Cowen, and the company said it would trade on the Nasdaq under the symbol APGE. The company, based in Waltham, Mass., seeks to develop “differentiated” treatments for atopic dermatitis, chronic obstructive pulmonary disease, and other illnesses with “high unmet need.” The company lost $12.5 million, or $2.51 a share, in the three months ended March 31, compared with losses of $4.3 million, or $4.19 a share, in the year-ago period. “Even if this offering is successful, we will require substantial additional capital to finance our operations in the future,” the company wrote as one of its risk factors in the prospectus.

Read the full article here

News Room June 23, 2023 June 23, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Trump threatens 30% tariffs on EU and Mexico, bitcoin tops $122K

Watch full video on YouTube

We Went To Canada To See The U.S. Product Boycotts — And What We Found Was Striking

Watch full video on YouTube

Bitcoin tops $123K, another S&P 500 target boost, Trump’s latest tariff wrath hits Mexico and the EU

Watch full video on YouTube

Why Applebee’s is struggling while Chili’s thrives

Watch full video on YouTube

Truist Financial Corporation (TFC) Q2 2025 Earnings Call Transcript

Truist Financial Corporation (NYSE:TFC) Q2 2025 Earnings Conference Call July 18, 2025…

- Advertisement -
Ad imageAd image

You Might Also Like

Investing

Why Home Builders Are Bouncing Today—and Why Their Stocks Are Good Buys

By News Room
Investing

This Beaten-Down Industrial Stock Wants to Call America Home. Why It’s Time to Buy.

By News Room
Investing

These 8 Dividend Aristocrats Can Protect Your Portfolio in a Downturn

By News Room
Investing

Some Lenders Benefit From SBA’s Troubled Loan Program

By News Room
Investing

Social Security Is in Turmoil. Should You Lock In Benefits Now?

By News Room
Investing

Hims & Hers Stock Is Due for a Crash Diet. The GLP-1 Surge Is Fading Fast.

By News Room
Investing

Opinion: The stock-market selloff isn’t over yet. Here are 4 reasons why.

By News Room
Investing

With Trump’s tariffs paused, ‘Big Three’ automakers may race to build inventories

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?